Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 772-785

  Xie, Chao ^a   Liang, Bojian ^a   Xue, Ming ^a   Lin, Angela S P ^b   Loiselle, Alayna ^a   Schwarz, Edward M ^a   Guldberg, Robert E ^b   O'Keefe, Regis J ^a   Zhang, Xinping ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYCLOOXYGENASE 2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E4 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLUS; CELL ISOLATION; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; FEMUR FRACTURE; FRACTURE HEALING; FRACTURE NONUNION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIMB BUD; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 68449103187     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081099     Document Type: Article

References (66)

1. Einhorn T: The cell and molecular biology of fracture healing. Clin Orthop 1998, 355S:S7-S21
2. Einhorn TA: The science of fracture healing. J Orthop Trauma 2005, 19:S4-6
3. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA: Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003, 88:873-884
4. Herschman HR: Prostaglandin synthase 2. Biochem Biophys Acta 1996, 1229:125-140
5. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 2000, 69:145-182
6. Raisz LG, Pilbeam CC, Fall PM: Prostaglandins: mechanisms of action and regulation of production in bone. Osteoporos Int 1993, 3 Suppl 1:136-140
7. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG: The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 1995, 96:36-46
8. Sugimoto Y, Narumiya S: Prostaglandin E receptors. J Biol Chem 2007, 282:11613-11617
9. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD: Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001, 41:661-690
10. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T: The role of prostaglandin E receptor subtypes (EP1. EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs Endocrinology 2000, 141:1554-1559
11. Weinreb M, Grosskopf A, Shir N: The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol 1999, 276:E376-E383
12. Li X, Okada Y, Pilbeam CC, Lorenzo JA, Kennedy CR, Breyer RM, Raisz LG: Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000, 141:2054-2061
13. Ono K, Kaneko H, Choudhary S, Pilbeam CC, Lorenzo JA, Akatsu T, Kugai N, Raisz LG: Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 2005, 20:23-29
14. Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, Paralkar VM, Owen TA, Cameron KO, Lefker BA, Brown TA, Thompson DD: A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003, 18:2033-2042
15. Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, Owen TA, Li M, DaSilva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchalk D, Vukicevic S, Thompson DD: An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 2003, 100:6736-6740
16. Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WS, Brown TA, Thompson DD: A non-prostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Miner Res 2006, 21:565-575
17. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M, Ito K, Ito Y, Sugimoto Y, Ushikubi F, Ohuchida S, Kondo K, Nakamura T, Narumiya S: Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 2002, 99:4580-4585
18. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002, 109:1405-1415
19. Simon AM, Manigrasso MB, O'Connor JP: Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002, 17:963-976
20. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, Fox N, Genovese M, Regula D, Smith RL: COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 2002, 20:1164-1169
21. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, Isakson PC, Geis GS: Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998, 41:1591-1602
22. Simon AM, Sabatino CT, O'Connor JP: Effects of cyclooxygenase-2 inhibitors on fracture healing. Trans Orthop Res Soc 2001, 26:205
23. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003, 21:670-675
24. Simon AM, O'Connor JP: Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am 2007, 89:500-511
25. Rundle CH, Strong DD, Chen ST, Linkhart TA, Sheng MH, Wergedal JE, Lau KH, Baylink DJ: Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat. J Gene Med 2008, 10:229-241
26. Aguirre JI, Leal ME, Rivera MF, Vanegas SM, Jorgensen M, Wronski TJ: Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats. J Bone Miner Res 2007, 22:877-888
27. Li M, Healy DR, Li Y, Cameron K, Ke HZ, Lefker BA, Rosati RL, Thompson DD: CP-463,755. A non-prostanoid EP2 receptor agonist stimulates fracture healing in a rat femoral fracture model. J Bone Miner Res 2000, 15:S343
28. Bonnarens F, Einhorn TA: Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984, 2:97-101
29. Duvall CL, Robert Taylor W, Weiss D, Guldberg RE: Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 2004, 287:H302-H310
30. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE: Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 2007, 22:286-297
31. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P: Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999, 14:1167-1174
32. Hildebrand T, Ruegsegger P: Quantification of Bone Microarchitecture with the Structure Model Index. Comput Methods Biomech Biomed Engin 1997, 1:15-23
33. Guldberg RE, Ballock RT, Boyan BD, Duvall CL, Lin AS, Nagaraja S, Oest M, Phillips J, Porter BD, Robertson G, Taylor WR: Analyzing bone, blood vessels, and biomaterials with microcomputed tomography. IEEE Eng Med Biol Mag 2003, 22:77-83
34. Sapirstein A, Saito H, Texel SJ, Samad TA, O'Leary E, Bonventre JV: Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1774-R1782
35. Zhang X, Ziran N, Goater JJ, Schwarz EM, Puzas JE, Rosier RN, Zuscik M, Drissi H, O'Keefe RJ: Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: tGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 2004, 34:809-817
36. Leber TM, Balkwill FR: Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997, 249:24-28
37. Brochhausen C, Neuland P, Kirkpatrick CJ, Nusing RM, Klaus G: Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ-prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther 2006, 8:R78
38. Jee WS, Ke HZ, Li XJ: Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats. Bone Miner 1991, 15:33-55
39. Jorgensen HR, Svanholm H, Host A: Bone formation induced in an infant by systemic prostaglandin-E2 administration. Acta Orthop Scand 1988, 59:464-466
40. Keila S, Kelner A, Weinreb M: Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol 2001, 168:131-139
41. Sibonga JD, Zhang M, Ritman EL, Turner RT: Restoration of bone mass in the severely osteopenic senescent rat. J Gerontol A Biol Sci Med Sci 2000, 55:B71-B78, discussion B79-B84
42. Schwartz Z, Gilley RM, Sylvia VL, Dean DD, Boyan BD: The effect of prostaglandin E2 on costochondral chondrocyte differentiation is mediated by cyclic adenosine 3′,5′-monophosphate and protein kinase C. Endocrinology 1998, 139:1825-1834
43. Schwartz Z, Sylvia VL, Curry D, Luna MH, Dean DD, Boyan BD: Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes. Endocrinology 1999, 140:2991-3002
44. Rosado E, Schwartz Z, Sylvia VL, Dean DD, Boyan BD: Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim Biophys Acta 2002, 1590:1-15
45. Sylvia VL, Schwartz Z, Dean DD, Boyan BD: Transforming growth factor-beta1 regulation of resting zone chondrocytes is mediated by two separate but interacting pathways. Biochim Biophys Acta 2000, 1496:311-324
46. Desai S, Ashby B: Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. FEBS Lett 2001, 501:156-160
47. Desai S, April H, Nwaneshiudu C, Ashby B: Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol 2000, 58:1279-1286
48. Fujino H, Salvi S, Regan JW: Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol Pharmacol 2005, 68:251-259
49. Fujino H, Regan JW: EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol Pharmacol 2006, 69:5-10
50. Kanaoka S, Takai T, Yoshida K: Cyclooxygenase-2 and tumor biology. Adv Clin Chem 2007, 43:59-78
51. Fosslien E: Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001, 31:325-348
52. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5:1418-1423
53. Dormond O, Foletti A, Paroz C, Ruegg C: NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat Med 2001, 7:1041-1047
54. Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T: Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 2004, 101:591-596
55. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M: Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 2005, 115:2979-2991
56. Colleselli D, Bijuklic K, Mosheimer BA, Kahler CM: Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation. Exp Cell Res 2006, 312:2933-2941
57. Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ: Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res 2006, 66:4378-4384
58. Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ: Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 2003, 102:1966-1977
59. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422
60. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628
61. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA: Altered fracture repair in the absence of MMP9. Development 2003, 130:4123-4133
62. Rousseau B, Ge PJ, Ohno T, French LC, Thibeault SL: Extracellular matrix gene expression after vocal fold injury in a rabbit model. Ann Otol Rhinol Laryngol 2008, 117:598-603
63. Agren MS: Gelatinase activity during wound healing. Br J Dermatol 1994, 131:634-640
64. Tomlinson ML, Garcia-Morales C, Abu-Elmagd M, Wheeler GN: Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development. Mech Dev 2008, 125:1059-1070
65. Hsu JY, Bourguignon LY, Adams CM, Peyrollier K, Zhang H, Fandel T, Cun CL, Werb Z, Noble-Haeusslein LJ: Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci 2008, 28:13467-13477
66. Manuel JA, Gawronska-Kozak B: Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. Matrix Biol 2006, 25:505-514